VERITAS EPI
Molecular pathologist examining a tissue slide by microscopy

The Test

An epigenetic assessment of biological aging

VERITAS EPI analyses DNA methylation patterns associated with biological aging and selected health related pathways, and reports them within clinical context.

At a glance

Five questions this page answers

Start here. Each question is answered in the sections below, in the order most people need them.

  1. 01

    What is it?

    A DNA methylation based assessment of biological aging signals.

  2. 02

    Why does it matter?

    Chronological age records time; it does not describe cellular change.

  3. 03

    How does it work?

    Consultation, sample, laboratory analysis, modelling, interpretation.

  4. 04

    What will I learn?

    A structured biological aging profile rather than a single number.

  5. 05

    What can it not tell me?

    It does not diagnose disease, predict lifespan or reverse aging.

01, What is it?

A measurement of epigenetic marks, not a change to your DNA

The assessment reads chemical marks on DNA, mainly methylation at CpG sites, that help regulate how genes are used.

Methylation patterns shift with age in ways that research groups have used to build biological age models. VERITAS EPI applies validated models of this kind to laboratory methylation data.

The result is a biological aging profile with several dimensions, each presented with its evidence level and limitations. It is intended for the people who should be interpreting it together: the individual and a qualified healthcare professional.

02, Why does it matter?

Chronological age tells one story. Biology tells another.

Two people of the same age can differ considerably in the biological changes taking place in their cells and tissues.

Chronological age is the time since birth. Biological aging describes what is happening inside the body over that time. Epigenetic information offers one measurable view of that process.

Used responsibly, it can add a layer of biological context to a prevention focused conversation. It does not replace medical history, examination or conventional laboratory testing.

03, How does it work?

From consultation to a clinical conversation

Each stage is documented. Specimen type, turnaround and laboratory details are published once confirmed for the final assay.

01

Learn

Understand what epigenetic testing can and cannot offer before deciding.

The Science and For Patients pages explain the concepts behind the assessment in plain language.

Researcher reviewing peer reviewed assay literature
02

Medical assessment

The individual and a healthcare professional decide whether testing is appropriate.

Intended use and target population will be published with the validated assay documentation.

Physician reviewing clinical information with a patient
03

Sample collection

A validated biological specimen is collected under documented conditions.

The specimen type (for example blood or saliva) is confirmed with the final assay. Information to be confirmed.

Healthcare professional collecting a blood specimen
04

Laboratory analysis and modelling

Sample processing, DNA extraction, methylation analysis, quality control, then computational analysis.

Validated algorithms translate methylation data into selected biological aging measures. Samples failing quality control are not reported.

Scientist operating a high throughput assay scanner
05

Medical interpretation

Results are placed alongside clinical history and conventional investigations.

Each measure is accompanied by its reference information, confidence and limitations.

Clinical scientist reviewing quality control and confidence plots
06

Discussion and follow up

The report highlights areas that may warrant discussion, monitoring or further clinical evaluation.

Whether repeat measurement is appropriate depends on the assay's validated methodology.

Doctor discussing a scientific report with a patient
Fig. M1Bisulfite conversion and read alignment

Illustrative representation of methylated and unmethylated CpG calls across aligned sequencing reads. Conceptual figure.

Fig. M2Sample by CpG site matrix
β 0.0β 1.0

Illustrative methylation matrix produced after quality control and normalisation. Conceptual figure, not clinical data.

04, What will I learn?

A biological aging profile, not a single score

The report is organised into modules so that every finding sits next to its explanation, its evidence and its limits.

Executive summary

A short overview of the main findings, written in plain clinical language so that patient and physician start from the same understanding.

Domains appear in a report only after they have been validated for the assay.

    01Executive summary
    02Epigenetic age
    03Age acceleration
    04Biological aging domains
    05Metabolic context
    06Lifestyle associated signals
    07Scientific interpretation
    08What this result means
    09Questions for your physician
    10Recommended follow up
    11Scientific references
    12Methodology
    13Limitations

How assessments differ

Not all biological age tests are the same

A neutral comparison of approaches. Items marked for VERITAS EPI are claimed only once verified for the final assay.

DNA methylation analysis

Consumer kit: Variable
Research assay: Yes
VERITAS EPI: Yes, confirmed for the final assay

Biological age model

Consumer kit: Variable
Research assay: Depends on the study
VERITAS EPI: Validated model, once documented

Medical context

Consumer kit: Limited
Research assay: Usually research only
VERITAS EPI: A core component

Physician involvement

Consumer kit: Usually limited
Research assay: Variable
VERITAS EPI: Designed around it

Clinical documentation

Consumer kit: Variable
Research assay: Research focused
VERITAS EPI: Required before publication

Repeat measurement

Consumer kit: Variable
Research assay: Study dependent
VERITAS EPI: Only on a validated pathway

Regulatory status

Consumer kit: Varies
Research assay: Research use
VERITAS EPI: Stated explicitly

05, What can it not tell me?

Clear boundaries around every result

Knowing the limits of a measurement is part of understanding it.

  1. 01

    It does not predict lifespan

    The assessment gives no life expectancy or individual longevity forecast.

  2. 02

    It does not diagnose disease

    It is not a diagnostic test and does not replace clinical investigation.

  3. 03

    It does not establish cause

    Associations reported in research do not explain an individual result.

  4. 04

    It does not reverse aging

    No claim is made that biological aging can be reversed or stopped.

  5. 05

    It does not stand alone

    Results are meant to be interpreted with a qualified healthcare professional.

  6. 06

    It carries uncertainty

    Each measure is reported with its confidence and reference limitations.

  1. Measure

    Laboratory methylation analysis under a documented quality system.

  2. Interpret

    Validated computational models with declared references.

  3. Contextualise

    Findings read alongside clinical history and conventional tests.

  4. Educate

    Plain language explanations, references and limitations.

Common questions

About the assessment

The specimen type will be confirmed with the validated assay and published in the sample requirements. Information to be confirmed.

Turnaround times will be published with the ordering workflow once laboratory operations are finalised.

The assessment is designed to be interpreted with a healthcare professional. Ordering requirements depend on the regulatory framework in each jurisdiction.

Repeat measurement is only meaningful when the methodology has been validated for it. This will be stated explicitly once confirmed.

Consent, storage and retention are described on the Quality, Regulatory and Privacy page.

Assay specifications to be confirmedRegulatory status to be stated